Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Heritage Cannabis Holdings Corp HERTF

Heritage Cannabis Holdings Corp. is a Canada-based cannabis company offering products to both the medical and recreational legal cannabis markets in Canada and the United States. It focuses on extraction and the creation of extract and extract-derivative products and brands for adult use and cannabis-based medical solutions. It has a portfolio of cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, Adults Only, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the United States. In Canada, it operates through its subsidiaries, Heritage Cannabis West Corporation (Heritage West) and Heritage Cannabis East Corporation (Heritage East). Heritage West holds a Health Canada issued cultivation, processing, and medical and adult use sales license, as well as an industrial hemp license, a cannabis oil sales license, and a cannabis research license. In the United States, it operates through, Opticann Inc., an oral and topical cannabinoid company.


PINL:HERTF - Post by User

Comment by lscfaon Sep 29, 2022 1:07am
130 Views
Post# 34994039

RE:Ebitda

RE:EbitdaCo. did show calc in MD&A for q3 but not q2....


 

Q ending

Jul 22

Apr 22

Jan 22

Gross margin

2,470,839

3,184,806

1,884,761

Less G&A exp.

(5,390,047)

(4,084,500)

(5,160,498)

depn/amort

1,243,398

1,264,921

1,279,734

stock comp

463,290

104,319

108,825

one-time charges

575,509

 

 

Professional fees

129,670

 

 

Rev product chg

668,317

 

 

Adj. ebitda

160,976

469,546

(1,887,178)

 

<< Previous
Bullboard Posts
Next >>